BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30638126)

  • 1. Regulation of RNA decay and cellular function by 3'-5' exoribonuclease DIS3L2.
    Luan S; Luo J; Liu H; Li Z
    RNA Biol; 2019 Feb; 16(2):160-165. PubMed ID: 30638126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs.
    Łabno A; Warkocki Z; Kuliński T; Krawczyk PS; Bijata K; Tomecki R; Dziembowski A
    Nucleic Acids Res; 2016 Dec; 44(21):10437-10453. PubMed ID: 27431325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dis3l2-Mediated Decay Is a Quality Control Pathway for Noncoding RNAs.
    Pirouz M; Du P; Munafò M; Gregory RI
    Cell Rep; 2016 Aug; 16(7):1861-73. PubMed ID: 27498873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs.
    Ustianenko D; Pasulka J; Feketova Z; Bednarik L; Zigackova D; Fortova A; Zavolan M; Vanacova S
    EMBO J; 2016 Oct; 35(20):2179-2191. PubMed ID: 27647875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Perlman syndrome DIS3L2 exoribonuclease safeguards endoplasmic reticulum-targeted mRNA translation and calcium ion homeostasis.
    Pirouz M; Wang CH; Liu Q; Ebrahimi AG; Shamsi F; Tseng YH; Gregory RI
    Nat Commun; 2020 May; 11(1):2619. PubMed ID: 32457326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of the exoribonucleases DIS3L2 and XRN1 in human disease.
    Pashler AL; Towler BP; Jones CI; Newbury SF
    Biochem Soc Trans; 2016 Oct; 44(5):1377-1384. PubMed ID: 27911720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a TUTase/RNase complex required for
    Lin CJ; Wen J; Bejarano F; Hu F; Bortolamiol-Becet D; Kan L; Sanfilippo P; Kondo S; Lai EC
    RNA; 2017 Mar; 23(3):284-296. PubMed ID: 27974621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The exoribonuclease Dis3L2 defines a novel eukaryotic RNA degradation pathway.
    Malecki M; Viegas SC; Carneiro T; Golik P; Dressaire C; Ferreira MG; Arraiano CM
    EMBO J; 2013 Jul; 32(13):1842-54. PubMed ID: 23503588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PNPT1 Release from Mitochondria during Apoptosis Triggers Decay of Poly(A) RNAs.
    Liu X; Fu R; Pan Y; Meza-Sosa KF; Zhang Z; Lieberman J
    Cell; 2018 Jun; 174(1):187-201.e12. PubMed ID: 29779946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel role for the 3'-5' exoribonuclease Dis3L2 in controlling cell proliferation and tissue growth.
    Towler BP; Jones CI; Harper KL; Waldron JA; Newbury SF
    RNA Biol; 2016 Dec; 13(12):1286-1299. PubMed ID: 27630034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A shape-shifting nuclease unravels structured RNA.
    Meze K; Axhemi A; Thomas DR; Doymaz A; Joshua-Tor L
    Nat Struct Mol Biol; 2023 Mar; 30(3):339-347. PubMed ID: 36823385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian DIS3L2 exoribonuclease targets the uridylated precursors of let-7 miRNAs.
    Ustianenko D; Hrossova D; Potesil D; Chalupnikova K; Hrazdilova K; Pachernik J; Cetkovska K; Uldrijan S; Zdrahal Z; Vanacova S
    RNA; 2013 Dec; 19(12):1632-8. PubMed ID: 24141620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis Triggers Specific, Rapid, and Global mRNA Decay with 3' Uridylated Intermediates Degraded by DIS3L2.
    Thomas MP; Liu X; Whangbo J; McCrossan G; Sanborn KB; Basar E; Walch M; Lieberman J
    Cell Rep; 2015 May; 11(7):1079-89. PubMed ID: 25959823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term survival of a patient with Perlman syndrome due to novel compound heterozygous missense mutations in RNB domain of DIS3L2.
    Soma N; Higashimoto K; Imamura M; Saitoh A; Soejima H; Nagasaki K
    Am J Med Genet A; 2017 Apr; 173(4):1077-1081. PubMed ID: 28328139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility.
    Astuti D; Morris MR; Cooper WN; Staals RH; Wake NC; Fews GA; Gill H; Gentle D; Shuib S; Ricketts CJ; Cole T; van Essen AJ; van Lingen RA; Neri G; Opitz JM; Rump P; Stolte-Dijkstra I; Müller F; Pruijn GJ; Latif F; Maher ER
    Nat Genet; 2012 Feb; 44(3):277-84. PubMed ID: 22306653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for DIS3L2 over natural nonsense-mediated mRNA decay targets in human cells.
    da Costa PJ; Menezes J; Saramago M; García-Moreno JF; Santos HA; Gama-Carvalho M; Arraiano CM; Viegas SC; Romão L
    Biochem Biophys Res Commun; 2019 Oct; 518(4):664-671. PubMed ID: 31466720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis for cytoplasmic RNA surveillance by uridylation-triggered decay in Drosophila.
    Reimão-Pinto MM; Manzenreither RA; Burkard TR; Sledz P; Jinek M; Mechtler K; Ameres SL
    EMBO J; 2016 Nov; 35(22):2417-2434. PubMed ID: 27729457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DIS3L2 and LSm proteins are involved in the surveillance of Sm ring-deficient snRNAs.
    Roithová A; Feketová Z; Vaňáčová Š; Staněk D
    Nucleic Acids Res; 2020 Jun; 48(11):6184-6197. PubMed ID: 32374871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical localization of exoribonucleases (DIS3L2 and XRN1) in intranuclear inclusion body disease.
    Mori F; Tanji K; Miki Y; Toyoshima Y; Sasaki H; Yoshida M; Kakita A; Takahashi H; Wakabayashi K
    Neurosci Lett; 2018 Jan; 662():389-394. PubMed ID: 29100804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for the Perlman syndrome exonuclease Dis3l2 in the Lin28-let-7 pathway.
    Chang HM; Triboulet R; Thornton JE; Gregory RI
    Nature; 2013 May; 497(7448):244-8. PubMed ID: 23594738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.